Rowland Carmichael Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $1.31M | Sell |
11,147
-93
| -0.8% | -$10.9K | 0.41% | 50 |
|
|
2020
Q3 | $1.17M | Buy |
11,240
+1,530
| +16% | +$159K | 0.46% | 53 |
|
|
2020
Q2 | $890K | Buy |
9,710
+2,486
| +34% | +$228K | 0.38% | 64 |
|
|
2020
Q1 | $651K | Sell |
7,224
-982
| -12% | -$88.5K | 0.33% | 81 |
|
|
2019
Q4 | $931K | Buy |
8,206
+57
| +0.7% | +$6.47K | 0.32% | 83 |
|
|
2019
Q3 | $885K | Sell |
8,149
-909
| -10% | -$98.7K | 0.3% | 85 |
|
|
2019
Q2 | $882K | Sell |
9,058
-84
| -0.9% | -$8.18K | 0.31% | 86 |
|
|
2019
Q1 | $833K | Sell |
9,142
-217
| -2% | -$19.8K | 0.31% | 90 |
|
|
2018
Q4 | $851K | Sell |
9,359
-2,530
| -21% | -$230K | 0.38% | 53 |
|
|
2018
Q3 | $1.17M | Buy |
11,889
+1,471
| +14% | +$145K | 0.45% | 43 |
|
|
2018
Q2 | $892K | Sell |
10,418
-481
| -4% | -$41.2K | 0.38% | 66 |
|
|
2018
Q1 | $874K | Buy |
10,899
+1,039
| +11% | +$83.3K | 0.48% | 72 |
|
|
2017
Q4 | $796K | Sell |
9,860
-129
| -1% | -$10.4K | 0.41% | 75 |
|
|
2017
Q3 | $777K | Buy |
9,989
+10
| +0.1% | +$778 | 0.43% | 69 |
|
|
2017
Q2 | $886K | Buy |
9,979
+548
| +6% | +$48.7K | 0.51% | 60 |
|
|
2017
Q1 | $760K | Sell |
9,431
-1,204
| -11% | -$97K | 0.46% | 69 |
|
|
2016
Q4 | $758K | Buy |
10,635
+70
| +0.7% | +$4.99K | 0.45% | 75 |
|
|
2016
Q3 | $913K | Sell |
10,565
-209
| -2% | -$18.1K | 0.58% | 62 |
|
|
2016
Q2 | $935K | Buy |
10,774
+1,566
| +17% | +$136K | 0.59% | 58 |
|
|
2016
Q1 | $691K | Buy |
+9,208
| New | +$691K | 0.64% | 55 |
|